--First data disclosure from Ribometrix’s RNA-targeting drug discovery platform identifies small molecules targeting c-MYC, a validated but historically undruggable cancer driver -- --Data shows ...
This is a preview. Log in through your library . Abstract The protooncogene MYC regulates a variety of cellular processes, including proliferation and metabolism. Maintaining MYC at homeostatic levels ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback